Fibrogenesis is estimated to contribute to nearly 40% of deaths in the Western world, yet it remains one of the most overlooked therapeutic targets. ECM2026 aims to change this by bringing together experts across disciplines to explore the extracellular matrix (ECM) as a driver of disease and a source of new treatment opportunities.

Selected topics include:
• Obesity and multi-organ fibrosis
• Emerging therapies and target discovery
• Fibroblasts and cancer
• Autoimmunity and chronic inflammation
• Lung and liver fibrosis
• Fibroaging
• Precision medicine

Join  ECM2026 in Copenhagen for, fresh ideas, bright science, and next-generation therapies. register on line : www.ecm-congress.org